Sanofi ADR (SNY)

Healthcare · Drug Manufacturers - General
$39.56 +0.13% on the day Market cap $97.3B 52-week range $39.18 to $52.68 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Sanofi ADR's free cash flow isn't comparable to its market value here, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

B

Five factors scored 1 to 9 from SNY's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation8
Profitability5
Growth9
Financial health4

Key numbers

P/E (trailing)17.7x
P/E (forward)8.09x
Price / free cash flow9.60x
EV / EBITDA12.3x
Price / sales2.05x
Price / book1.15x
Revenue growth—
Operating margin—
Net margin—
Return on equity10.9%
Dividend yield0.0%
Debt / equity0.77x

Results from SEC filings

Fiscal years, from Sanofi ADR's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue—————
Net income$6.2B$8.4B$5.4B$5.6B$7.8B
Free cash flow$8.5B$8.4B$7.4B$5.9B$7.2B
EPS (diluted)$4.95$6.66$4.30$4.43$6.37
Operating margin—————

Superinvestors who own SNY

From each investor's latest 13F filing (what a 13F shows). 6 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Dodge & Cox
Dodge & Cox
Trimmed $1.2B0.63%Q2 2026
Charles Brandes
Brandes Investment Partners, LP
Added $176M1.2%Q2 2026
Cliff Asness
AQR Capital Management
Added $11M0.00%Q2 2026
PRIMECAP Management
PRIMECAP Management Co
Held $4M0.00%Q2 2026
Lee Ainslie
Maverick Capital
Added $2M0.02%Q2 2026
Richard Pzena
Pzena Investment Management
Added $1M0.00%Q2 2026

Insider buying

Open-market purchases by Sanofi ADR's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of SNY in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when SNY trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are Sanofi ADR insiders buying the stock?

No open-market insider purchases of SNY in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Sanofi ADR?

6 of the superinvestors Investingly tracks hold SNY in their latest 13F, including Dodge & Cox, Charles Brandes, Cliff Asness.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.